1 |
(r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1h-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone |
Pyrazole |
- |
- |
- |
075 [1] 75 💬 |
2 |
(r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)4,4a,5,6,7,8-hexahydro-1h-pyrazolo[3,4-g]isoquinolin-4a-yl)(4(trifluoromethyl)pyridin-2-yl)methanone |
Pyrazole |
- |
- |
- |
075 [1] 75 💬 |
3 |
17beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one |
- |
- |
- |
- |
075 [1] 75 💬 |
4 |
17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one |
- |
- |
- |
- |
075 [1] 75 💬 |
5 |
18f-dopa |
- |
- |
- |
- |
006 [3] 6 , 17, 75 💬 |
6 |
1h-pyrazol |
Pyrazole |
- |
- |
- |
028 [3] 28, 46, 75 💬 |
7 |
2s,4r-(-)-ketoconazole |
Ketoconazole |
[1] D00351 D00351 💬 |
CYP17A1 [1] CYP17A1 💬 |
Cortisol synthesis and secretion [6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
075 [1] 75 💬 |
8 |
2s,4r-(-)-ketoconazole, levoketoconazole |
Ketoconazole |
[2] D00351 D00351, D10950 D10950 💬 |
CYP17A1 [1] CYP17A1 💬 |
Cortisol synthesis and secretion [6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
075 [1] 75 💬 |
9 |
Abiraterone |
Abiraterone |
[1] D09701 D09701 💬 |
- |
- |
075 [2] 75, 81 💬 |
10 |
Abiraterone acetate |
Abiraterone |
[1] D09701 D09701 💬 |
- |
- |
075 [2] 75, 81 💬 |
11 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
12 |
Acthrel |
- |
- |
- |
- |
075 [1] 75 💬 |
13 |
Atr-101 |
- |
- |
- |
- |
075 [2] 75, 81 💬 |
14 |
Azd4017 |
- |
- |
- |
- |
075 [1] 75 💬 |
15 |
Azd4017 and prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
16 |
Bexarotene |
Bexarotene |
[1] D03106 D03106 💬 |
RXRA [3] RXRA, RXRB, RXRG 💬 |
Adipocytokine signaling pathway [15] Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
013 [2] 13, 75 💬 |
17 |
Cabergoline |
Cabergoline |
[1] D00987 D00987 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 74, 75 💬 |
18 |
Cabergoline teva |
Cabergoline |
[1] D00987 D00987 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 [1] 75 💬 |
19 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
20 |
Calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
013 [8] 13, 19, 46, 53, 75, 96, 235, 299 💬 |
21 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 [12] 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
22 |
Ci-984 |
- |
- |
- |
- |
075 [1] 75 💬 |
23 |
Cialis - 20 mg 2 compresse rivestite con film in blister uso orale |
- |
- |
- |
- |
075 [1] 75 💬 |
24 |
Cor-003 |
- |
- |
- |
- |
075 [1] 75 💬 |
25 |
Cort125134 |
Relacorilant |
[1] D11336 D11336 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
26 |
Corticotropin |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [7] 2 , 13, 46, 75, 78, 84, 222 💬 |
27 |
Corticotropin-releasing hormone |
Corticorelin |
[2] D00146 D00146, D03905 D03905 💬 |
CRHR1 [3] CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
28 |
Cushing's syndrome confirmation |
- |
- |
- |
- |
075 [1] 75 💬 |
29 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d) trp-ly di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
30 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d)trp-ly di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
31 |
Cyclo((diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
32 |
Cyclo(diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) |
- |
- |
- |
- |
075 [1] 75 💬 |
33 |
Ddavp |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
075 [2] 75, 288 💬 |
34 |
Device: continuous glucose monitoring |
Dextrose, unspecified form |
- |
- |
- |
075 [2] 75, 299 💬 |
35 |
Device: ipc |
- |
- |
- |
- |
075 [1] 75 💬 |
36 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
37 |
Diagnostic test: 24-hour urine test |
- |
- |
- |
- |
075 [1] 75 💬 |
38 |
Diagnostic test: blood test |
- |
- |
- |
- |
075 [1] 75 💬 |
39 |
Diagnostic test: ct scan |
- |
- |
- |
- |
075 [1] 75 💬 |
40 |
Diagnostic test: dexamethasone test |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
41 |
Diagnostic test: mri |
- |
- |
- |
- |
075 [1] 75 💬 |
42 |
Diagnostic test: saliva swab |
- |
- |
- |
- |
075 [1] 75 💬 |
43 |
Dostinex |
- |
- |
- |
- |
075 [1] 75 💬 |
44 |
Dotatate |
Dotatate |
- |
- |
- |
041 [3] 41, 75, 84 💬 |
45 |
Eplerenone |
Eplerenone |
[1] D01115 D01115 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
075 [4] 75, 113, 210, 215 💬 |
46 |
Gefitinib |
Gefitinib |
[1] D01977 D01977 💬 |
EGFR [1] EGFR 💬 |
Adherens junction [46] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis |
075 [1] 75 💬 |
47 |
Genotropin 12mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
48 |
Genotropin 5.3mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
49 |
Genotropin miniqu |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
50 |
Genotropin miniquick 0.2mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
51 |
Genotropin miniquick 0.4mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
52 |
Genotropin miniquick 0.6mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
53 |
Genotropin miniquick 0.8mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
54 |
Genotropin miniquick 1.0mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
55 |
Genotropin miniquick 1.2mg |
- |
- |
- |
- |
074 [3] 74, 75, 78 💬 |
56 |
Glucocorticoids |
- |
- |
- |
- |
040 [8] 40, 41, 43, 44, 60, 62, 75, 300 💬 |
57 |
Glucophage (metformin) |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 [2] 46, 75 💬 |
58 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 [15] 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
59 |
Hra052015 |
- |
- |
- |
- |
075 [1] 75 💬 |
60 |
Hra052015 (mifepristone) |
Mifepristone |
[1] D00585 D00585 💬 |
NR3C1 [2] NR3C1, PGR 💬 |
Breast cancer [5] Breast cancer, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation |
075 [1] 75 💬 |
61 |
Hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [9] 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
62 |
Hypro |
- |
- |
- |
- |
075 [1] 75 💬 |
63 |
Insulin |
- |
- |
- |
- |
013 [5] 13, 46, 75, 78, 299 💬 |
64 |
Ketoconazole |
Ketoconazole |
[1] D00351 D00351 💬 |
CYP17A1 [1] CYP17A1 💬 |
Cortisol synthesis and secretion [6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 [3] 8 , 13, 75 💬 |
65 |
L0006cp03a |
- |
- |
- |
- |
075 [1] 75 💬 |
66 |
La |
- |
- |
- |
- |
006 [5] 6 , 13, 75, 76, 222 💬 |
67 |
Lapatinib |
Lapatinib |
[2] D04024 D04024, D08108 D08108 💬 |
EGFR [2] EGFR, ERBB2 💬 |
Adherens junction [48] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction |
034 [3] 34, 74, 75 💬 |
68 |
Lci699 |
- |
- |
- |
- |
075 [1] 75 💬 |
69 |
Lci699, 1 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
70 |
Lci699, 10 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
71 |
Lci699, 20 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
72 |
Lci699, 5 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
73 |
Levoketoconazole |
Levoketoconazole |
[1] D10950 D10950 💬 |
- |
- |
075 [1] 75 💬 |
74 |
Levoketozonazole |
- |
- |
- |
- |
075 [1] 75 💬 |
75 |
Liqourice |
- |
- |
- |
- |
075 [1] 75 💬 |
76 |
Liraglutide |
Liraglutide |
[1] D06404 D06404 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [3] 6 , 75, 193 💬 |
77 |
Lmwh/rivaroxaban |
Rivaroxaban |
[1] D07086 D07086 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
075 [1] 75 💬 |
78 |
Matyrapone |
- |
- |
- |
- |
075 [1] 75 💬 |
79 |
Metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
80 |
Methionine |
Methionine |
[2] D00019 D00019, D04983 D04983 💬 |
- |
- |
034 [7] 34, 75, 84, 93, 229, 298, 300 💬 |
81 |
Metopirone |
- |
- |
- |
- |
075 [1] 75 💬 |
82 |
Metopirone 250 mg capsules |
- |
- |
- |
- |
075 [1] 75 💬 |
83 |
Metopirone 250 mg capsules/cormeto |
- |
- |
- |
- |
075 [1] 75 💬 |
84 |
Metyrapone |
Metyrapone |
[2] D00410 D00410, D05019 D05019 💬 |
CYP11B1 [1] CYP11B1 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
075 [2] 75, 193 💬 |
85 |
Mifedren |
- |
- |
- |
- |
075 [1] 75 💬 |
86 |
Mifepristone |
Mifepristone |
[1] D00585 D00585 💬 |
NR3C1 [2] NR3C1, PGR 💬 |
Breast cancer [5] Breast cancer, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation |
075 [1] 75 💬 |
87 |
Nevanimibe |
Nevanimibe |
[1] D11300 D11300 💬 |
- |
- |
075 [2] 75, 81 💬 |
88 |
Nevanimibe hydrochloride |
Nevanimibe |
[1] D11300 D11300 💬 |
- |
- |
075 [2] 75, 81 💬 |
89 |
Nizoral |
- |
- |
- |
- |
075 [1] 75 💬 |
90 |
Octreotide |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [7] 67, 75, 84, 85, 89, 193, 227 💬 |
91 |
Orocal |
- |
- |
- |
- |
075 [1] 75 💬 |
92 |
Osilodrostat |
Osilodrostat |
[1] D11061 D11061 💬 |
CYP11B2 [1] CYP11B2 💬 |
Aldosterone synthesis and secretion [3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 [1] 75 💬 |
93 |
Osilodrostat 10mg |
Osilodrostat |
[1] D11061 D11061 💬 |
CYP11B2 [1] CYP11B2 💬 |
Aldosterone synthesis and secretion [3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 [1] 75 💬 |
94 |
Osilodrostat 1mg |
Osilodrostat |
[1] D11061 D11061 💬 |
CYP11B2 [1] CYP11B2 💬 |
Aldosterone synthesis and secretion [3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 [1] 75 💬 |
95 |
Osilodrostat 20mg |
Osilodrostat |
[1] D11061 D11061 💬 |
CYP11B2 [1] CYP11B2 💬 |
Aldosterone synthesis and secretion [3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 [1] 75 💬 |
96 |
Osilodrostat 5mg |
Osilodrostat |
[1] D11061 D11061 💬 |
CYP11B2 [1] CYP11B2 💬 |
Aldosterone synthesis and secretion [3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis |
075 [1] 75 💬 |
97 |
Ossein hydroxyapatite |
- |
- |
- |
- |
075 [1] 75 💬 |
98 |
Osteopor |
- |
- |
- |
- |
075 [1] 75 💬 |
99 |
Other: [11c]-methionine pet/mri |
Methionine |
[2] D00019 D00019, D04983 D04983 💬 |
- |
- |
075 [1] 75 💬 |
100 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
101 |
Other: hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
102 |
Other: obese |
- |
- |
- |
- |
075 [1] 75 💬 |
103 |
Ovine corticotropin-releasing hormone (ocrh) |
Corticorelin |
[2] D00146 D00146, D03905 D03905 💬 |
CRHR1 [3] CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
104 |
Pasireotida |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
105 |
Pasireotida 300 |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
106 |
Pasireotida 600 |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
107 |
Pasireotida 900 |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
108 |
Pasireotide |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [3] 67, 74, 75 💬 |
109 |
Pasireotide 0.3mg |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
110 |
Pasireotide 0.6 mg/ml |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
111 |
Pasireotide 0.6mg |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
112 |
Pasireotide 0.9 mg |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
113 |
Pasireotide 20mg |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
114 |
Pasireotide 40mg |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
115 |
Pasireotide 60mg |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
116 |
Pasireotide diaspartate |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
117 |
Pasireotide lar |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [2] 67, 75 💬 |
118 |
Pasireotide pamoate |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
119 |
Pasireotide s.c. |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
120 |
Pasireotide sub-cutaneous |
Pasireotide |
[1] D10147 D10147 💬 |
SSTR1 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
121 |
Pasireotide with or without cabergoline |
Cabergoline |
[2] D00987 D00987, D10147 D10147 💬 |
DRD2 [6] DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Alcoholism [14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 [1] 75 💬 |
122 |
Pasireotode |
- |
- |
- |
- |
075 [1] 75 💬 |
123 |
Pentetreotide |
Pentetreotide |
[1] D01859 D01859 💬 |
- |
- |
075 [1] 75 💬 |
124 |
Phe |
- |
- |
- |
- |
075 [2] 75, 240 💬 |
125 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
126 |
Procedure: hypercortisolism |
- |
- |
- |
- |
075 [1] 75 💬 |
127 |
Procedure: lateral transperitoneal la |
- |
- |
- |
- |
075 [1] 75 💬 |
128 |
Procedure: posterior ra |
- |
- |
- |
- |
075 [1] 75 💬 |
129 |
R-roscovitine |
Seliciclib |
- |
- |
- |
075 [1] 75 💬 |
130 |
Radiation: dotatate pet-ct |
Dotatate |
- |
- |
- |
075 [1] 75 💬 |
131 |
Radiation: f-dopa pet ct |
- |
- |
- |
- |
075 [1] 75 💬 |
132 |
Relacorilant |
Relacorilant |
[1] D11336 D11336 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
133 |
Rivaroxaban |
Rivaroxaban |
[1] D07086 D07086 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
046 [5] 46, 49, 75, 91, 210 💬 |
134 |
Rosiglitazone |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [5] 46, 75, 97, 222, 265 💬 |
135 |
Rosiglitazone maleate |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [3] 46, 75, 265 💬 |
136 |
Rvg 08938 |
- |
- |
- |
- |
075 [1] 75 💬 |
137 |
Rvg 15375 |
- |
- |
- |
- |
075 [1] 75 💬 |
138 |
Rvg 18236 |
- |
- |
- |
- |
075 [2] 75, 227 💬 |
139 |
Seliciclib |
Seliciclib |
- |
- |
- |
075 [2] 75, 299 💬 |
140 |
Signifor |
- |
- |
- |
- |
075 [1] 75 💬 |
141 |
Sitagliptin |
Sitagliptin |
[1] D08516 D08516 💬 |
DPP4 [1] DPP4 💬 |
Protein digestion and absorption [1] Protein digestion and absorption |
006 [4] 6 , 75, 233, 299 💬 |
142 |
Som230 |
- |
- |
- |
- |
074 [2] 74, 75 💬 |
143 |
Som230 300µg |
- |
- |
- |
- |
075 [1] 75 💬 |
144 |
Som230 600µg |
- |
- |
- |
- |
075 [1] 75 💬 |
145 |
Som230 900µg |
- |
- |
- |
- |
075 [1] 75 💬 |
146 |
Som230 lar |
- |
- |
- |
- |
075 [1] 75 💬 |
147 |
Som230 lar 10 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
148 |
Som230 lar 30 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
149 |
Som230 lar, 20 mg |
- |
- |
- |
- |
075 [1] 75 💬 |
150 |
Som230 s.c. |
- |
- |
- |
- |
075 [1] 75 💬 |
151 |
Som230, 300micrograms |
- |
- |
- |
- |
075 [1] 75 💬 |
152 |
Som230, 600 micrograms |
- |
- |
- |
- |
075 [1] 75 💬 |
153 |
Som230, 900 micrograms |
- |
- |
- |
- |
075 [1] 75 💬 |
154 |
Som230b |
- |
- |
- |
- |
075 [1] 75 💬 |
155 |
Somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [16] 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
156 |
Tadalafil |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [7] 6 , 51, 75, 84, 86, 113, 210 💬 |
157 |
Tretinoin |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 [2] 2 , 75 💬 |
158 |
Trp |
- |
- |
- |
- |
075 [1] 75 💬 |
159 |
Tyr |
- |
- |
- |
- |
075 [2] 75, 298 💬 |
160 |
Valsartan |
Valsartan |
[1] D00400 D00400 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 [7] 57, 58, 66, 75, 218, 222, 224 💬 |
161 |
Vorinostat |
Vorinostat |
[1] D06320 D06320 💬 |
HDAC1 [11] HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis |
019 [3] 19, 75, 96 💬 |